Aspiriant LLC
IDEV icon

Aspiriant LLC’s iShares Core MSCI International Developed Markets ETF IDEV Stock Holding History

Aspiriant LLC’s Portfolio IDEV Stock Details IDEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.3M Buy
137,499
+21,214
+18% +$1.93M 0.3% 43
2026
Q2 		$10.4M Buy
116,285
+5,573
+5% +$494K 0.26% 47
2026
Q1 		$9.25M Buy
110,712
+7,986
+8% +$687K 0.26% 45
2025
Q4 		$8.47M Buy
+102,726
New +$8.35M 0.24% 49

Other funds holding IDEV

Bank of Finland
Bank of Finland Helsinki, Finland $1.38B AUM 11.75% 1-Year Est. Return
Auto-Owners Insurance
Auto-Owners Insurance Lansing, Michigan $3.2B AUM 21.13% 1-Year Est. Return
Foster Group
Foster Group West Des Moines, Iowa $3.68B AUM 13.84% 1-Year Est. Return
Riversedge Advisors
Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return
FPN
Financial Planning Navigators Maple Grove, Minnesota $274M AUM 13.83% 1-Year Est. Return
SAM
Standpoint Asset Management Scottsdale, Arizona $514M AUM 14.59% 1-Year Est. Return
Acropolis Investment Management
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
VC
Veery Capital Wilmington, Delaware $375M AUM 14.26% 1-Year Est. Return
Signature Estate & Investment Advisors
Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $508M AUM 11.76% 1-Year Est. Return

Aspiriant LLC's IDEV Position: Q3 2026 in Review

Aspiriant LLC increased its iShares Core MSCI International Developed Markets ETF (IDEV) stake by 18% in Q3 2026, buying an estimated $1.93M and bringing the position to 137,499 shares worth $12.3M. The position accounts for 0.3% of the portfolio, ranked #43.

Aspiriant LLC first reported a position in IDEV in Q4 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold IDEV as of Q3 2026.

  • Aspiriant LLC held 137,499 shares of iShares Core MSCI International Developed Markets ETF worth $12.3M as of Q3 2026.
  • Aspiriant LLC bought 21,214 iShares Core MSCI International Developed Markets ETF shares in Q3 2026, an estimated $1.93M.
  • iShares Core MSCI International Developed Markets ETF made up 0.3% of Aspiriant LLC's portfolio in Q3 2026, its #43 holding.
  • Aspiriant LLC first reported a position in iShares Core MSCI International Developed Markets ETF in Q4 2025 and has held it in 4 quarters since.
  • 183 funds tracked by Wall St. Rank held iShares Core MSCI International Developed Markets ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.